Polycystic Ovary Syndrome in Adolescence

    Susan K. Blank, Kristin D. Helm, Christopher R. McCartney, John C. Marshall
    Studysummary This article proposes a hypothesis that hyperandrogenemia is the final common pathway for developing adolescent PCOS and emphasizes the importance of reducing androgen levels to mitigate risks of metabolic syndrome, diabetes, and infertility in adulthood.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on nyaspubs.onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Polycystic Ovary Syndrome: Early Detection in Adolescents Clinical obstetrics and gynecology · 2007
    2. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    3. Health Care-Related Economic Burden of Polycystic Ovary Syndrome During the Reproductive Life Span The Journal of Clinical Endocrinology and Metabolism · 2005
    4. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients The Journal of Clinical Endocrinology and Metabolism · 2004